300 related articles for article (PubMed ID: 14709620)
1. Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidases.
Dalvie DK; O'Connell TN
Drug Metab Dispos; 2004 Jan; 32(1):49-57. PubMed ID: 14709620
[TBL] [Abstract][Full Text] [Related]
2. Metabolic aromatization of N-alkyl-1,2,3,4-tetrahydroquinoline substructures to quinolinium by human liver microsomes and horseradish peroxidase.
Gu C; Collins R; Holsworth DD; Walker GS; Voorman RL
Drug Metab Dispos; 2006 Dec; 34(12):2044-55. PubMed ID: 16985099
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
4. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
Usuki E; Pearce R; Parkinson A; Castagnol N
Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
[TBL] [Abstract][Full Text] [Related]
5. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
Prakash C; Wang W; O'Connell T; Johnson KA
Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolic activation of thiabendazole via 5-hydroxythiabendazole: identification of a glutathione conjugate of 5-hydroxythiabendazole.
Dalvie D; Smith E; Deese A; Bowlin S
Drug Metab Dispos; 2006 Apr; 34(4):709-17. PubMed ID: 16434547
[TBL] [Abstract][Full Text] [Related]
7. P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometry.
Mali'n TJ; Weidolf L; Castagnoli N; Jurva U
Rapid Commun Mass Spectrom; 2010 May; 24(9):1231-40. PubMed ID: 20391593
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 oxidation of the thiophene-containing anticancer drug 3-[(quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic acid (4-trifluoromethoxy-phenyl)-amide to an electrophilic intermediate.
Medower C; Wen L; Johnson WW
Chem Res Toxicol; 2008 Aug; 21(8):1570-7. PubMed ID: 18672911
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s.
He M; Rettie AE; Neal J; Trager WF
Drug Metab Dispos; 2001 May; 29(5):701-11. PubMed ID: 11302937
[TBL] [Abstract][Full Text] [Related]
10. Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap mass spectrometry and an improved mass defect filtering technique.
Ruan Q; Zhu M
Chem Res Toxicol; 2010 May; 23(5):909-17. PubMed ID: 20297803
[TBL] [Abstract][Full Text] [Related]
11. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases.
Herraiz T; Guillén H; Galisteo J
Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675
[TBL] [Abstract][Full Text] [Related]
12. Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.
Castagnoli N; Rimoldi JM; Bloomquist J; Castagnoli KP
Chem Res Toxicol; 1997 Sep; 10(9):924-40. PubMed ID: 9305573
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
14. Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction.
Labutti J; Parsons I; Huang R; Miwa G; Gan LS; Daniels JS
Chem Res Toxicol; 2006 Apr; 19(4):539-46. PubMed ID: 16608165
[TBL] [Abstract][Full Text] [Related]
15. Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo.
Valadon P; Dansette PM; Girault JP; Amar C; Mansuy D
Chem Res Toxicol; 1996 Dec; 9(8):1403-13. PubMed ID: 8951246
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
17. First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives.
Dansette PM; Bertho G; Mansuy D
Biochem Biophys Res Commun; 2005 Dec; 338(1):450-5. PubMed ID: 16137656
[TBL] [Abstract][Full Text] [Related]
18. The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A.
Savi P; Combalbert J; Gaich C; Rouchon MC; Maffrand JP; Berger Y; Herbert JM
Thromb Haemost; 1994 Aug; 72(2):313-7. PubMed ID: 7831671
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols.
Reddy VB; Karanam BV; Gruber WL; Wallace MA; Vincent SH; Franklin RB; Baillie TA
Chem Res Toxicol; 2005 May; 18(5):880-8. PubMed ID: 15892582
[TBL] [Abstract][Full Text] [Related]
20. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
